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ABSTRACT
Rectal carcinoma represents a significant health problem in the modern world. Its high rate of occurrence 
and mortality in the late stages of the disease stresses the need for better diagnostic, prognostic and predic-
tive methods. We present a review of the literature concerning the staging modalities, including the char-
acteristics of early rectal carcinoma. Endoscopy, endoluminal ultrasound and magnetic resonance imag-
ing play a major role in the preoperative staging and the restaging of rectal carcinoma. The new devices and 
technologies improve the diagnostic process, thus providing an option for new management strategies and 
better results.
Keywords: early rectal cancer, diagnostics, endoscopy, chromoendoscopy, endorectal ultrasonography, 
magnetic resonance
INTRODUCTION
Rectal carcinoma represents a significant health 
problem in the modern world. Its high rate of occur-
rence and mortality in the late stages of the disease 
stresses the need for better diagnostic, prognostic 
and predictive methods. The emergence of new data 
resulting from the researchers conducted on molec-
ular level improved the understanding about the oc-
currence and progression of the tumours. The com-
plexity and heterogeneity of the disease have been in-
creased, which explains why so few biological mark-
ers find routine application in clinical practice. Spo-
radic cancer arises as a result of genetic and epigen-
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etic changes, accumulated in the cell over the time 
of its life (1). These changes lead to a dysregulation 
of sensitive mechanisms, which in turn violates the 
normal cell proliferation and growth. Colorectal 
cancer develops randomly in most cases, although a 
small percentage of cases are a result of inherited mu-
tations or inflammatory diseases of the colon (such 
as Crohn’s disease and ulcerative colitis). According 
to modern oncological standards, the staging of rec-
tal cancer depends on the time of diagnosis. The bi-
ological nature of the tumour is still not a subject of 
routine testing. According to previously introduced 
and used oncological standards, the most important 
factor, influencing the results of the operative treat-
ment and survival rates, is the existence of metasta-
sis (2,3). No more than 6-8% of patients in the first 
stage of the disease present recurrence and progres-
sion with distant metastases in the lymph nodes and 
the liver. Widely used conventional methods and cri-
teria for cancer staging estimate the external pheno-
typic expression, rate of progression of the neoplastic 
process- excessive growth, local invasion, metastasis, 
but do not give information about the minimal resid-
ual disease and its effects on survival rates (4).
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Rectal cancer starts its development from one 
cell or a group of cells that have lost their ability for 
controlled growth and integration with the functions 
of the macroorganism. Depending on the degree of 
development, it can be divided into the following 
subtypes: early- limited by the basal layer of the mu-
cosa; invasive – passing through the basal layer of the 
mucosa and advanced- a cancer present with lymph 
node metastasis or distant metastasis.
According to the TNM classification, early can-
cer means carcinoma in situ, which is marked as Tis. 
Its frequency, according to different scientific studies 
varies from 0.2% to 11% (4) and increases courtesy of 
the screening programs.  In an asymptomatic group 
of patients, older than 50 years, who have passed di-
rect colonoscopy, the established frequency of adeno-
carcinoma is 1.8%, of which 50% were carcinoma in 
situ. (5). Frequency between 3% and 4.6% has been 
reported from the conducted screening programmes 
after a positive immunologic fecal test for occult 
bleeding (1). In 2006, Rubio (18) reports 10 cases of 
patients with colon hyperplastic polyposis syndrome 
and presents a systematic review, demonstrating that 
50% (70/147) of all patients present with this syn-
drome develop rectal cancer. Bearing in mind that 
cancerous cells most often develop from adenoma-
tous cells, the main role for increasing the number 
of patients with early diagnosed cancer is the detec-
tion and removal of malignant polyps of the colon 
and rectum (6).
Characteristics of Early Rectal Carcinoma
Histology: Carcinoma in situ, intra-mucous 
carcinoma, high-grade dysplasia or intra-epitheli-
al neoplasia is all stages of the disease, in which the 
muscularis propria layer is not involved. In general, 
cancer at this stage does not metastasise. It is clas-
sified as pTis or stage 0 according to the TNM clas-
sification. These terms are defined as non-invasive 
high-grade neoplasia according to the Vienna classi-
fication (6). Carcinoma in situ, high-grade dysplasia 
or intra-epithelial neoplasia  corresponds to cancer, 
limited to the epithelial layer without invasion in to 
the lamina propria. Intra-mucous carcinoma invades 
the lamina propria layer. When the cancer extends 
to the sub-mucous layer, the polyp is considered ma-
lignant with a possibility of metastasising in lymph 
nodes or extra-regional localisation. Tumours, in-
volving the sub-mucous layer are classified as T1 ac-
cording to the TNM classification and correspond to 
the first clinical stage, provided that no regional or 
distant metastasis is present. (7) The term “pseudo-
invasion” refers to cases in which glandular epitheli-
um from the mucous layer is present under the mus-
cularis propria layer of the colonic polyps. These le-
sions have no malignant potential and can be treated 
as adenomas (7). This phenomenon can be confused 
with invasive carcinoma by an inexperienced pathol-
ogist. Pseudo-invasion occurs in large polyps (over 1 
cm), especially in those with large peduncles and is 
most frequently seen in polyps localised in the sig-
moid colon. Islands of adenomatous epithelium are 
localised in the muscularis mucosae layer and the 
submucous layer of the peduncle.
Morphology: The Paris classification (tab.1) di-
vides the lesions based on morphological principles 
into polypoidal (pedunculated or sessile) and non-
polypoidal (flat or ulcerated) (fig.1) (8). The endosco-
pist should be familiar with the features of the lesion 
that reveal its malignant character. Such features are 
size, presence of ulcerative concaves, irregular con-
tour, deformities, short and rigid peduncle, inabili-
ty to lift a sessile polyp by infiltrating the submucous 
layer with serum. Non-polypoidal rectal neoplasms 
often develop into carcinoma (sub-mucous invasive 
carcinoma) compared to polypoidal neoplasms, re-
gardless of size (4).  Suspected lesions might be di-
agnosed using chromo-endoscopy and magnify-
ing technique to highlight anomalies in the glandu-
lar structures and reveal the depth of the submuco-
sal invasion (6). Kudo (8) classified colon polyps in 
six groups according to the findings of magnifica-
tion endoscopy with indigo-carmine dye, comple-
menting the diagnostic data before the endoscopic 
treatment. The endoscopic ultrasound, performed 
with endorectal ultrasound, endoscopic ultrasound 
or trans-endoscopic ultrasound miniprobes, is the 
most accurate method of assessing the submucous or 
deeper invasion in the colonic wall. This might help 
to send patients with deeper infiltration and high-
er risk of lymph node metastases directly to surgical 
treatment (12). 
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The known prognostic factors are: invasion of 
the colonic wall, penetration to the mesorectal fascia 
(circumferential resection margin) and presence of 
extraregional metastases. Those factors are assessed 
by the methods of imaging diagnostics. The exam-
inations, that give indications for local excision of 
early rectal carcinoma, are endorectal ultrasonogra-
phy (ERUS) and magnetic resonance imaging (MRI). 
ERUS is the most accurate method for evaluation of 
tumour invasion to the rectal wall, especially for the 
early stages (T1-T2) (13).
ERUS can evaluate the penetration of the tu-
mour in the mesorectal fatty tissue in T3 tumours, 
but cannot assess the circumferential resection mar-
gin. The rectal wall can be assessed also by MRI, as 
this method can establish penetration to the meso-
rectal fascia, although with lower accuracy for T1-
T2 tumours. Both methods have similar efficacy for 
evaluation of the regional lymph nodes. The ERUS 
can detect pathologically enlarged and hypoechoic 
lymph nodes and the MRI - lymph nodes over 1cm. 
The risk of lymph metastases is close to 0%, although 
some new studies establish for tumours in Kakuchi 
stage sm1 that the risk approximates 1%-3%, for sm2 
it reaches 8% and in sm3 – up to 23% (15). The selec-
tion of the patients for curative endoscopic resection 
MRI and ERUS must be performed before the pro-
cedure (16-18). The specificity of the endoscopic ul-
trasound devices allows for endoluminal localisation 
of the colonic tumours. Some authors report results 
of ultrasound examination of neoplasms of the colon 
with significant specificity and sensitivity. The ear-
ly rectal carcinoma can be treated with the methods 
Table 1. Paris classification of newly discovered neoplasms of the colon and rectum
Type of lesion Characteristics
1. Type 0-I Polypoidal lesions
    -(0-Ip) Pedunculated lesion
    -(0-Is) Flat lesions
2. Type 0-II Non-raised and non-concave lesions
    -(0-IIa) Slightly raised
    -(0-IIb) Completely f lat lesions
    -(0-IIc) Slightly concave lesions without ulcerations
3. Type 0-III Non-polypoidal lesions with ulcerations
of endoscopic surgery (14). The treatment of colorec-
tal cancer has developed significantly in the recent 
years and the exact preoperative staging plays an im-
portant role in the choice of the optimal multimodal 
strategy. Prognostic factors such as the depth of tu-
mour invasion (T-stage) and the number of engaged 
lymph nodes (N-stage) is easily evaluated by ERUS. 
Correct staging is crucial to properly select the pa-
tients, the needed preoperative therapy and to choose 
the optimal surgical method (5). The contemporary 
methods for preoperative staging of colorectal can-
cer include computer tomography (CT), endorectal 
ultrasonography (ERUS), magnetic-resonance imag-
ing (MRI), positrone-emission tomography (PET). 
Choosing the imaging modality is defined by its 
availability in the medical centre and the experience 
with its use (6). Since the introduction of endorectal 
ultrasound (ERUS) in the early 80 s̀ (6,7) it has had a 
wide use in the everyday clinical practice as it plays 
important role in the diagnostic and staging of the 
malignant neoplasms of the gastro-intestinal tract 
and the adjacent structures. ERUS was applied in rec-
tal cancer staging in 1985 with promising results (9) 
and now it is accepted as a method for diagnostics of 
rectal tumours, being considered a quick, safe meth-
od with high staging accuracy (10). The depth of in-
vasion in the rectal wall and the adjacent structures is 
a powerful predictive factor for survival and plays an 
important role in the choice of the treatment strate-
gy. The accuracy of the T-staging varies according to 
different literature data. A retrospective study over a 
10-year period reports of 69% overall accuracy for T-
staging (11). The validation of ERUS staging was done 
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by comparing the pathological stage of the resected 
tumours. T3 tumors were staged with higher accura-
cy (86%) and the differentiation between T1 and T2 
stage was considered especially difficult. Overstag-
ing was common (19%) and in only 12% understag-
ing was observed. The authors notice high variabili-
ty between the different physicians and correlation of 
higher accuracy with better experience. When com-
paring different frequencies, 10MHz gives better re-
sults than 7.5MHz but only in T1 tumours. Other au-
thors report of 81% accuracy in preoperative T-stag-
ing in a series of 424 patients, where the examination 
was performed by experienced surgeons (12). In a 
prospective multicentre study of application of ERUS 
in clinical practice the overall accuracy was 68.5%, 
less than the previously reported data, probably due 
to the lack of experience (16). The highest sensitivi-
ty was achieved for T3 tumours (74.9%). Meta-analy-
sis for the period 1980-2008 demonstrated high sen-
sitivity of ERUS in the evaluation of the tumour in-
vasion (88%-95%) and better results were achieved in 
the more advanced stages of the disease (13). 
In rectal cancer it is very important to differ-
entiate between the early and the advanced stage. 
In a prospective study the selection of patients was 
performed according to the ERUS-stage and the 
achieved accuracy was 95% (18). Another group of 
authors reports of 96% sensitivity, 85% specificity 
and 94% accuracy in the differentiation of early and 
advanced rectal cancer. A meta-analysis strongly rec-
ommends ERUS for the staging of early tumours, be-
cause of its excellent sensitivity and specificity in the 
diagnostics of T0 stage (97.3% and 96.3%, respective-
ly) (20). Although the results vary, a common ten-
dency is established in the abovementioned studies. 
The accuracy of endorectal ultrasonographic staging 
varies for the T-stage and the uT2 tumours are diag-
nosed most often (13). This is a result of overstaging. 
The better results depend on the physician’s experi-
ence (11,21). For patients with stenosing tumours the 
staging is suboptimal, because the ERUS probe can-
not pass through. In these cases despite the advanced 
stage of the tumour a catheter ultrasound miniprobe 
is recommended (22), or dilatation of the tumour, 
followed by ERUS.
N-stage
A significant disadvantage of ERUS for routine 
staging of rectal carcinoma is its low accuracy in the 
evaluation of regional lymph nodes, which varies be-
tween 70% and 75% (22.23). Retrospective study pre-
sented unsatisfactory results in 68% overall accuracy 
in N-staging, 52% sensitivity and 82% specificity (14). 
This confirms previous results from other groups 
who reported 10 years with 64% accuracy in the di-
agnosis of lymphatic metastases (15). A review of 35 
studies over two decades, gave the following results: 
73.2% pooled sensitivity, specificity 75.8% (16). An-
other conclusion of this meta-analysis is that ERUS 
is doing better in the exclusion of lymphatic metas-
tases than in their establishment. One reason for the 
faulty interpretation of the image, leading to poor 
diagnostic results is the presence of altered reactive 
inflammatory lymph nodes. It is difficult to distin-
guish from malignant lymph nodes based only on 
the ultrasound characteristics, leading to false-pos-
itive results, the problem being the size of the nodes. 
While positive lymph nodes are generally round, hy-
poechogenic and over 5 mm in diameter (16-20) as 
metastatic foci were reported in approximately 18% 
of the nodes below 5 millimeters. One study that de-
serves attention found that the frequency of met-
astatic lymph nodes was 9.5% for ≤ 2mm nodes in 
the shortest diameter, 47% for nodes between 3 and 
5 mm and 87% in nodules ≥ 6 mm (14). A new study 
examines the accuracy of the determination of ERUS 
lymph stage correlated with depth of invasion of pri-
mary tumour.
In less invasive tumours the size of lymph nodes 
and metastatic sites, the accuracy of the method de-
creases (17). The ERUS ability to correctly identify 
lymph status decreased significantly from 84% for 
pT3 tumours to 48% in pT1 tumours, in which case 
the average size of the nodes as metastatic sites was 
respectively 3.3 mm and 0.3 mm. In conclusion, early 
tumours have small metastatic foci that are released 
more frequently in ERUS. This may be the cause of 
pelvic recurrence after local excision. The logical 
question is whether patients with early cancer should 
be indicated for local excision only with ERUS stag-
ing. One solution to this problem is to reduce the size 
as a criterion. This can increase the responsiveness of 
34  Scripta Scientifica Medica, vol. 46, No 1, 2014, 30-36
Copyright © Medical University of Varnaa
Diagnostic modalities for early rectal cancer
the method for the establishing of the lymphatic me-
tastases, but will lead to a lower overall accuracy and 
specificity. When the limit is 5 mm, responsiveness, 
specificity and accuracy in diagnosing ERUS T1 le-
sions is about 38%, 94% and 89% while with the low-
ering of the limit to 3 mm, the values were 75%, 49% 
and 53% (13).
The development and improvement of new 
technologies make endoscopic ultrasonography 
method of great clinical significance in diseases of the 
digestive system in terms of diagnosis, staging and 
prognosis (16). These new techniques are applicable 
to rectal tumors. The three-dimensional ultrasound 
(3D-ERUS) improves the study of spatial relations 
of rectal cancer and better staging and assessment 
of the respective. You can use linear or radial trans-
ducer. Three-dimensional reconstruction is achieved 
more easily with radial than with linear transducer 
while manual control and transducer angulation can 
lead to artifacts (17). Therefore, 3D-ERUS is a more 
accurate method than the two-dimensional CT and 
2D-ERUS in the staging of rectal cancer. The accu-
racy of 3D-ERUS, 2D-ERUS and CT in assessing the 
depth of tumour infiltration was 78%, 69% and 57%, 
while the evaluation of lymph status was 65%, 56% 
and 53%. The most common cause of misinterpreta-
tion of the image is human error. 3D-ERUS provides 
more information about the depth of invasion and 
shows conical growths along the deep border of the 
tumour, which correlates well with the histological 
evidence of the degree of infiltration, more advanced 
T stage and lymph metastases (20).
Special software facilitates the manipulation 
with the rectal probe and makes 3D reconstruc-
tion easier. These 3D images provide better visual-
isation of mesorectal borders, thereby overcoming 
one of the 2D ultrasonography (17). 3D-ERUS con-
tributes to the endoscopic mucosal resection of early 
tumours being a safer and more effective procedure 
(15). Elastrography is an innovation in the endoscop-
ic ultrasound and explores the elastic properties of 
tissues, and this way it may contribute to differences 
between the malignant lesions of fibrous tissue and 
the benign ones. Preliminary data suggest that the 
combination of elastography with ERUS improves 
T-staging in rectal cancer. This method simulates a 
virtual palpation, and can thus identify lymph nodes 
that are more likely to be malignant and to increase 
the diagnostic accuracy of the ERUS fine needle bi-
opsy. Contrast-enhanced endoscopic ultrasonogra-
phy is a modern method, which uses contrast in the 
bloodstream, increasing the Doppler signal, which 
facilitates the evaluation of tumour perfusion. Al-
though this method has not yet been fully explored, 
it is expected to become the method of functional di-
agnostics for the evaluation of response to neoadju-
vant therapy. Apart from high resolution, this meth-
od provides information on changes in tumour vas-
cularisation. Transfer of recognised principles for ul-
trasound staging of rectal tumours with topical study 
of lesions of the colon can help to improve results of 
radical surgical treatment of rectal cancer. 
Future direction 
Findings from the recent analyses did not lead 
to a revolution in rectal cancer. Constructed hypoth-
eses must be validated by different methods of anal-
ysis before recommendations are made for the clin-
ical use of biomarkers. The latest technological ad-
vance is the introduction of the method of sequen-
tial analysis. The identification of variants and muta-
tions in individual tumours revealed certain tumor-
specific abnormalities. They may find clinical use as 
prognostic and predictive factors, and also help the 
development of individualised therapeutic strategy. 
The increasing number of therapies targeting specif-
ic genes and signalling pathways emphasises the role 
of the normal functioning of genes to achieve the de-
sired effect. With the better identification and valida-
tion of biomarkers, they will lead to a greater range 
of choice of therapy. Optimisation of the predictive 
methods for the development of cancer diagnosis at 
an early stage, giving the most correct prediction, 
prediction of therapeutic response - these are of great 
importance to patients, medical staff, but also to so-
cio-economics to run. 
CONCLUSION
Endoscopic ultrasonography has been demon-
strated as an accurate method for local staging of 
rectal cancer. Despite its limitations, a wider appli-
cation in clinical practice would improve treatment 
outcomes. New methods like 3D-ERUS, elastography 
and contrast enhancement would provide additional 
data to improve the diagnostic accuracy of endoscop-
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ic ultrasound to expand its role, to make its use rou-
tine in the complex treatment of colorectal cancer. 
While performing colonoscopy there may also occur 
complications. Since endoscopy has been playing an 
increasing therapeutic role, there will probably be an 
increase in the number of complications. Knowing 
the potential endoscopic complications, the expected 
frequency and risk factors help to reduce the number 
of complications. Endoscopy must conduct a careful 
selection of patients in the planned procedure to be 
familiar with the plan of procedure and equipment, 
and be prepared to deal with possible accidents. In 
the event of a complication there should be done an 
early diagnosis and intervention to reduce morbidity 
and mortality rate associated with this complication.
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